Reliance Industries, through its subsidiary Reliance Strategic Business Ventures (RSBVL), has acquired the oncology-focused healthcare platform Karkinos for Rs 375 crore. The acquisition was completed ...

Karkinos was incorporated in India on July 24, 2020, and is in the business of providing technology-driven innovative solutions for the early detection, diagnosis, and management of cancer.

Reliance Industries has bought the technology-driven oncology platform Karkinos Healthcare for ₹375 crore through Reliance Strategic Business Ventures. The deal consists of ₹10 crore equity ...

Recent acquisition Karkinos Healthcare boosts its digital healthcare presence. Major investments include Hathway Cable and REC Solar. RIL aims to enhance its healthcare services using advanced ...

Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.

The crab figure holds meaning, as cancerous tumors were likened to cancers in ancient times, which is why the disease was named 'karkinos'. "Today, the word 'cancer' used also takes its name from ...

Billionaire Mukesh Ambani's Reliance Industries has acquired technology-driven and oncology-focused healthcare platform Karkinos for Rs 375 crore, the firm said on Saturday. Reliance Strategic ...

The acquisition strengthens Reliance's healthcare portfolio, focusing on technology-driven cancer detection and treatment solutions Reliance Industries has completed the acquisition of Karkinos ...

Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer ...

Reliance Industries has successfully acquired Karkinos Healthcare, a technology-focused oncology platform, for Rs 375 crore. The deal has been made by the Reliance Strategic Business Ventures, ...

Reliance Industries has acquired Karkinos Healthcare, a technology-driven oncology platform, for Rs 375 crore. Reliance Strategic Business Ventures (RSBVL), a wholly-owned subsidiary of Reliance ...